GCL
OACC

Glazer Capital LLC’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Glazer Capital LLC’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.79M Sell
357,922
-7,178
-2% -$76.4K 0.08% 197
2025
Q4 		$3.86M Hold
365,100
– – 0.1% 152
2025
Q3 		$3.84M Hold
365,100
– – 0.13% 134
2025
Q2 		$3.81M Sell
365,100
-22,497
-6% -$233K 0.14% 100
2025
Q1 		$3.96M Buy
+387,597
New +$3.89M 0.18% 76

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Glazer Capital LLC's OACC Position: Q1 2026 in Review

Glazer Capital LLC reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 2% in Q1 2026, selling an estimated $76.4K and leaving 357,922 shares worth $3.79M. The position accounts for 0.08% of the portfolio, ranked #197.

Glazer Capital LLC first reported a position in OACC in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.96M in Q1 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Glazer Capital LLC held 357,922 shares of Oaktree Acquisition Corp III Life Sciences worth $3.79M as of Q1 2026.
  • Glazer Capital LLC sold 7,178 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $76.4K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.08% of Glazer Capital LLC's portfolio in Q1 2026, its #197 holding.
  • Glazer Capital LLC first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Glazer Capital LLC's Oaktree Acquisition Corp III Life Sciences position peaked at $3.96M in Q1 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Glazer Capital LLC's 13F filing for Q1 2026, filed 14 May 2026.